“I think it will help you as a doctor to know you’re doing a treatment not only for 3 months, but that the treatment benefit is going to last for at least 2 years,” said Yvo Roos, MD. “It’s going to help you be more convincing to the relatives that you’re doing the right thing, that you’re doing something that’s really going to help them."
The above quote is in reference to new long-term followup data published as of April 6th, 2017, which now confirms and extends the outcomes of the MR CLEAN endovascular therapy trial in acute ischemic stroke patients. The results show that 1 out of every 3 patients treated with catheter based intervention are returning home to care for themselves within 3 months and these results are durable up to 2 years! Read the full details of the follow up data right here.
Max Landon: Jun 04, 2025
UCHealth Memorial Hospital is Using Pulsara to Facilitate Feedback, Education, and Better Outcomes Across Organizations What if the future of...
Audrey Peart: May 29, 2025
May Recap May was our busiest month of the year so far. From EMS Week Conferences to Preparedness Summits to Stroke Symposiums, our teams were busy...
Team Pulsara: May 23, 2025
Today is EMS Recognition Day, the final day of EMS Week and a time to recognize and celebrate the people who take on the challenge of serving their...
Brittney Nelson, BSN, RN, SCRN